胃癌组织中HER-2/neu、PTEN及CD44V6的表达与预后

Expression of HER-2/neu,PTEN and CD44V6 in gastric cancer tissue and its correlation with the prognosis of gastric cancer

  • 摘要: 目的 探讨胃癌组织中HER-2/neu、PTEN及CD44V6的表达与预后的关系。方法 应用免疫组织化学法检测65例胃癌标本和30例正常组织中HER-2/neu、PTEN及CD44V6的表达情况。结果 HER-2/neu、PTEN及CD44V6在胃癌组织中阳性率分别为21.5%、36.9%及58.5%;在正常胃粘膜组织中的阳性率分别为10.0%、90.0%及10.0%;二者差异有统计学意义(P<0.05);在胃癌组织中的表达与肿瘤分化程度、侵袭深度以及淋巴结是否转移相关(P<0.05)。CD44V6与HER-2/neu表达阳性及阴性的5年生存率分别为7.14%和22.2%。Cox回归生存分析显示HER-2/neu和CD44V6同时阳性表达是强危险因素。结论 胃癌组织中HER-2/neu及CD44V6的阳性表达提示患者预后差,可作为评价预后的指标。

     

    Abstract: Objective To study the expression of HER-2/neu,PTEN and CD44V6 proteins in gastric cancer and its correlation with the prognosis of gastric cancer. Methods Expressions of HER-2/neu,PTEN and CD44V6 proteins in 30 normal tissue samples and 65 gastric cancer tissue samples were detected with immunohistochemical staining. Results The positive rate of HER-2/neu,PTEN and CD44V6 expression was 21.5%,36.9%and 58.5%,respectively,in gastric cancer tissue samples,and 10.0%,90.0%and 10.0%,respectively,in normal tissue samples(P<0.05).The expression of HER-2/neu,PTEN and CD44V6 in gastric cancer was closely related with tumor cell differentiation,invasion depth and lymph node metastasis(P<0.05) but not with age,sex and pathological stages of patients(P>0.05).The 5-year survival rate for patients with positive or negative expression of CD44V6 and HER-2/neu was 7.14%and 22.2%,respectively(P<0.05).Cox regression analysis showed that the expression of HER-2/neu and CD44V6 proteins was a risk factor for gastric cancer. Conclusion Expression of HER-2/neu,PTEN and CD44V6 proteins in gastric cancer can be used as an indicator for predicting the prognosis of gastric cancer.

     

/

返回文章
返回